长风药业（02652）于2026年10月5日发布公告，披露公司于当日通过香港联交所场内交易方式回购70,700股普通股H股，占回购前已发行股本的约0.0219%。每股回购价格介于6.695港元至7.2港元之间，合计支付约49.93万港元。回购完成后，公司已发行股本（不含库藏股）变更为322,093,986股，库藏股增至1,877,300股，总已发行股份数则保持323,971,286股不变。
公告显示，此次回购基于2026年6月26日获通过的购回授权，购回数量上限为30,082,658股。截至目前，公司已在香港联交所及其他交易所合计回购480,300股，占购回授权通过日已发行股本约0.1597%。本次回购完成后，公司仍在回购后30天的股票发行、出售或转让暂止期内。
公司确认已遵守香港联交所证券上市规则及相关法律法规。公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.